![Amy Schacterle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Schacterle
Generell Rådgivare på
ACUMEN PHARMACEUTICALS, INC.
Förmögenhet: 263 064 $ per 2026-08-31
Profil
Amy Schacterle is currently Chief Regulatory Officer & Head-Quality at Acumen Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Schacterle was Vice President-Regulatory Affairs at Sumitomo Pharma America, Inc. from 2004 to 2014 and Senior VP-Global Regulatory Affairs & Policy at SAGE Therapeutics, Inc. from 2017 to 2020.
Education includes undergraduate studies at Rensselaer Polytechnic Institute and graduate and doctorate degrees from the University of Virginia.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-16 | 92 303 ( 0,13 % ) | 263 064 $ | 2026-08-31 |
Aktiva positioner av Amy Schacterle
| Företag | Position | Start |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Generell Rådgivare | 2024-11-06 |
Tidigare kända positioner av Amy Schacterle
| Företag | Position | Slut |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-01-01 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Generell Rådgivare | 2014-01-01 |
Amy Schacterles utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
